| PERIOD ENDING | 2-Jan-09 | 28-Dec-07 | 29-Dec-06 | | Total Revenue | 1,329,234 | 1,222,270 | 940,150 | | Cost of Revenue | 680,098 | 609,365 | 479,069 | | | Gross Profit | 649,136 | 612,905 | 461,081 | | | Operating Expenses | | Research Development | 148,265 | 131,468 | 103,840 | | Selling General and Administrative | 290,313 | 279,067 | 212,039 | | Non Recurring | 2,722 | 5,137 | 1,930 | | Others | 22,376 | 18,966 | 7,906 | | | | Total Operating Expenses | 463,676 | 434,638 | 325,715 | | | | Operating Income or Loss | 185,460 | 178,267 | 135,366 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 741 | 12,091 | 6,295 | | Earnings Before Interest And Taxes | 194,722 | 190,358 | 148,650 | | Interest Expense | 2,760 | 6,602 | 558 | | Income Before Tax | 191,962 | 183,756 | 148,092 | | Income Tax Expense | 50,490 | 66,382 | 44,434 | | Minority Interest | 540 |
-
|
-
| | | | Net Income From Continuing Ops | 141,472 | 117,374 | 103,658 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 141,472 | 117,374 | 103,658 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $141,472 | $117,374 | $103,658 |
|
1.48% Nasdaq 
Income Statement
